Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis

NCT01808118 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

673

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

BIOLOGICAL: adalimumab
BIOLOGICAL: Placebo

Sponsor

AbbVie